Journal of Peking University (Health Sciences) ›› 2025, Vol. 57 ›› Issue (5): 975-979. doi: 10.19723/j.issn.1671-167X.2025.05.024

Previous Articles     Next Articles

Comparison of efficacy and safety of oral mucosa grafts and acellular dermal matrix grafts in the treatment of long-segment urethral stricture

Wenyuan LENG, Duan GAO, Xiaoyu LI, Wei ZUO, Weimin HU, Zhenpeng ZHU, Chunru XU, Jian LIN*(), Xuesong LI*()   

  1. Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China
  • Received:2025-02-27 Online:2025-10-18 Published:2025-06-09
  • Contact: Jian LIN, Xuesong LI
  • Supported by:
    the National Natural Science Foundation of China(82270708)

RICH HTML

  

Abstract: Objective: To investigate the differential efficacy and safety profiles of oral mucosa (OM) grafts compared with acellular dermal matrix (ADM) grafts in the surgical management of long-segment urethral strictures. Methods: A retrospective cohort study was conducted involving 27 patients who underwent graft urethroplasty for long-segment urethral strictures in Peking University First Hospital, spanning from May 2010 to September 2023. The patient cohort comprised 14 individuals who received OM grafts and 13 who underwent ADM grafts. The participants were stratified into two groups based on the type of grafts material utilized during surgery. The demographic and clinical baseline characteristics included an average age of (43.3±14.0) years in the OM group and (54.2±15.9) years in the ADM group. The mean body mass index (BMI) for the respective groups were (24.7±4.3) kg/m2 for OM and (25.4±4.8) kg/m2 for ADM. Etiological differences were noted, with idiopathic causes predominantly in the OM cohort and lichen sclerosus in the ADM cohort. Results: The surgical interventions were successfully executed for all the patients. The median stricture length was 4.5 (2.5, 9.0) cm for the OM group and 5.0 (2.0, 14.0) cm for the ADM group (P=0.555). The median operative duration was 160 (71, 221) min for the OM group and 134 (112, 274) min for the ADM group (P=0.065). The catheterization durations was 1.5 (1.0, 6.0) months for the OM group and 3.0 (1.0, 3.0) months for the ADM group. The median postoperative follow-up duration was 12.5 (1.0, 170.0) months for the OM group and 59.0 (3.0, 142.0) months for the ADM group. The surgical success rates were 50.00% in the OM group and 53.85% in the ADM group. No statistically significant differences were observed in postoperative quality of life (QoL) or international prostate symptom score (IPSS) at the final follow-up. The stricture-free survival rates did not differ significantly (HR=0.875, 95%CI: 0.507-1.511, P=0.6). In terms of safety, three patients in the OM group experienced sexual dysfunction, and two had oral complications, whereas the ADM group had one case of postoperative infection. Conclusion: The findings suggest that ADM grafts are comparable to OM grafts in terms of efficacy and safety for the treatment of long-segment urethral strictures, including complex cases attributed to lichen sclerosus. However, given the small sample size of this study, the above conclusions may have certain limitations. Larger cohort studies will be needed in the future to further validate these findings.

Key words: Urethral stricture, Urethroplasty, Acellular dermal matrix, Oral mucosa

CLC Number: 

  • R699.6

Table 1

Comparison of demographic and surgical characteristics between two groups"

Characteristics Group P value
OM ADM
Patient number 14 13
Age/years, ${\bar x}$±s 43.3±14.0 54.2±15.9 0.071
BMI/(kg/m2), ${\bar x}$±s 24.7±4.3 25.4±4.8 0.717
Smoking history, n (%) 3 (21.43) 3 (23.08) 0.946
Alcohol use history, n (%) 2 (14.29) 0 (0) 0.181
Comorbidities, n (%)
  Hypertension 2 (14.29) 1 (7.69) 0.624
  Diabetes 0 (0) 3 (23.08) 0.068
  Cardiovascular disease 2 (14.29) 0 (0) 0.181
Etiology, n (%) 0.035
  Trauma 2 (14.29) 3 (23.08)
  Lichen sclerosus 1 (7.14) 5 (38.46)
  Iatrogenic 5 (35.71) 4 (30.77)
  Idiopathic 6 (42.86) 1 (7.69)
Stricture site, n (%) 0.149
  Anterior urethra 14 (100.00) 11 (84.62)
  Posterior urethra 0 (0) 1 (7.69)
  Entire urethra 0 (0) 1 (7.69)
Stricture length/cm, median (min, max) 4.5 (2.5, 9.0) 5.0 (2.0, 14.0) 0.555
Prior surgeries, n (%) 0.652
  0 6 (42.86) 4 (30.77)
  1 1 (7.14) 4 (30.77)
  2 2 (14.29) 2 (15.38)
  3 0 (0) 2 (15.38)
  4 0 (0) 0 (0)
  ≥5 5 (35.71) 1 (7.69)
Operative duration/min, median (min, max) 160 (71, 221) 134 (112, 274) 0.065

Table 2

Comparison of clinical efficacy and safety between two surgical repair grafts across etiological subtypes"

Etiology (n) Group (n) Restricture rate, n (%) Median restricture time/months Complication (n)
Trauma (5) OM (2) 1 (50.0) 3 Oral pain (1)
ADM (3) 1 (33.3) 6
Lichen sclerosus (6) OM (1) 0 (0)
ADM (5) 3 (60.0) 6 Postoperative infection (1)
Iatrogenic (9) OM (5) 3 (60.0) 3 Dysgeusia (1)
ADM (4) 2 (50.0) 4.5
Idiopathic (7) OM (6) 3 (50.0) 3 Sexual dysfunction (3)
ADM (1) 0 (0)

Table 3

Comparative analysis of follow-up indicators between two groups"

Indicators Group P value
OM ADM
Preoperative QoL, median (min, max) 5.0 (5.0, 6.0) 6.0 (4.0, 6.0) 0.275
Preoperative IPSS, median (min, max) 20.5 (9.0, 31.0) 20.0 (15.0, 32.0) 0.800
Catheterization duration/months, median (min, max) 1.5 (1.0, 6.0) 3.0 (1.0, 3.0) 0.018
Restricture rate, n (%) 7 (50.00) 6 (46.15) 0.867
Restricture time/months, median (min, max) 2.5 (1.3, 8.0) 5.0 (1.5, 12.0) 0.163
Postoperative QoL, median (min, max) 1.0 (0, 5.0) 1.0 (0, 5.0) 0.358
Postoperative IPSS, median (min, max) 5.5 (3.0, 14.0) 7.0 (2.0, 14.0) 0.547

Figure 1

Comparison of stricture-free survival rates in two groups OM, oral mucosa; ADM, acellular dermal matrix."

1
Lumen N , Campos-Juanatey F , Greenwell T , et al. European Association of Urology guidelines on urethral stricture disease (Part 1): Management of male urethral stricture disease[J]. Eur Urol, 2021, 80 (2): 190- 200.

doi: 10.1016/j.eururo.2021.05.022
2
Wessells H , Angermeier KW , Elliott S , et al. Male urethral stricture: American Urological Association guideline[J]. J Urol, 2017, 197 (1): 182- 190.

doi: 10.1016/j.juro.2016.07.087
3
Lumen N , Hoebeke P , Willemsen P , et al. Etiology of urethral stricture disease in the 21st century[J]. J Urol, 2009, 182 (3): 983- 987.

doi: 10.1016/j.juro.2009.05.023
4
徐月敏. 尿道狭窄的病因与治疗现状[J]. 中华泌尿外科杂志, 2011, 32 (11): 725- 727.
5
Levy AC , Vanni AJ . Refractory urethral stricture management: Indications for alternative grafts and flaps[J]. Curr Urol Rep, 2018, 19 (3): 20.

doi: 10.1007/s11934-018-0769-0
6
Pastorek D , Culenova M , Csobonyeiova M , et al. Tissue engineering of the urethra: From bench to bedside[J]. Biomedicines, 2021, 9 (12): 1917.

doi: 10.3390/biomedicines9121917
7
Barbagli G , Akbarov I , Heidenreich A , et al. Anterior urethroplasty using a new tissue engineered oral mucosa graft: Surgical techniques and outcomes[J]. J Urol, 2018, 200 (2): 448- 456.

doi: 10.1016/j.juro.2018.02.3102
8
Ram-Liebig G , Barbagli G , Heidenreich A , et al. Results of use of tissue-engineered autologous oral mucosa graft for urethral reconstruction: A multicenter, prospective, observational trial[J]. EBioMedicine, 2017, 23, 185- 192.

doi: 10.1016/j.ebiom.2017.08.014
9
陈彩芳, 曾铭强, 薛睿智, 等. 男性尿道狭窄病因与治疗方式[J]. 中南大学学报(医学版), 2018, 43 (5): 520- 527.
10
Hevia M , Fraile A , Sanz E , et al. Does aetiology of urethral stricture influence the survival of the buccal mucosa graft? Comparative study in patients with penile urethral stricture due to lichen sclerosus vs. idiopathic group[J]. Transl Androl Urol, 2022, 11 (11): 1512- 1522.

doi: 10.21037/tau-21-1149
11
林健, 郝金瑞, 金杰, 等. 人同种异体真皮脱细胞基质在尿道重建中的临床应用[J]. 中华医学杂志, 2005, 85 (15): 1057- 1059.
12
徐月敏, 张炯, 傅强, 等. 小肠黏膜下脱细胞基质修复前尿道狭窄的疗效分析[J]. 中华泌尿外科杂志, 2011, 32 (6): 419- 422.
13
Palminteri E , Toso S , Preto M , et al. Small intestinal submucosa graft bulbar urethroplasty is a viable technique: Results compared to buccal mucosa graft urethroplasty after propensity score matching[J]. World J Urol, 2024, 42 (1): 123.

doi: 10.1007/s00345-024-04795-8
14
Abramowitz D , Sam AP , Pachorek M , et al. Multi-institutional review of non-hypospadiac penile urethral stricture management and outcomes[J]. Int J Urol, 2022, 29 (5): 376- 382.

doi: 10.1111/iju.14786
15
Phan K , Kim JS , Kim JH , et al. Anesthesia duration as an independent risk factor for early postoperative complications in adults undergoing elective ACDF[J]. Global Spine J, 2017, 7 (8): 727- 734.

doi: 10.1177/2192568217701105
[1] Jie WANG, Jianwei WANG, Haizhui XIA, Xiao XU, Jianpo ZHAI, Feng HE, Guanglin HUANG, Guizhong LI. Surgical management of the distal urethral stricture diseases [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1075-1082.
[2] WANG Jian-wei,XU Xiao,BAO Zheng-qing,LIU Zhen-hua,HE Feng,HUANG Guang-lin,MAN Li-bo. Outcomes of partial pubectomy assisted anastomotic urethroplasty for male patients with pelvic fracture urethral distraction defect [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 798-802.
[3] Chun-long ZHANG,He LI,Qing LI,Wen-jun BAI,Tao XU,Xiao-wei ZHANG. Decision regret analysis among Chinese patients receiving penile girth enhancement with acellular dermal matrix [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 678-683.
[4] Jian-wei WANG,Li-bo MAN,Xiao XU,Zhen-hua LIU,Feng HE,Guang-lin HUANG,Jian-po ZHAI,Ning ZHOU,Wei LI. Combined transperineal and transpubic urethroplasty for patients with complex male pelvic fracture urethral distraction defect [J]. Journal of Peking University (Health Sciences), 2020, 52(4): 646-650.
[5] Zhong-cheng XIN,Bi-cheng YANG,Meng LI,Yi-ming YUAN,Wan-shou CUI,Yuan TANG,Dong FANG,Wei-dong SONG. Appllication of human acellular dermal matrix in surgical treatment of genitourinary disease [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 778-782.
[6] Jian-wei WANG,Li-bo MAN,Guang-lin HUANG,Feng HE,Hai WANG,Hai-dong WANG,Xiao XU,Wei LI,Jian-po ZHAI,Zhen-hua LIU. Single-stage repair of penile urethral stricture using combined dorsal onlay oral mucosa grafting with ventral onlay penile skin flap [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 641-645.
[7] Ting-min XU,Xiao-wei ZHANG,Guo-xi ZHANG,Wen-jun BAI,Qing LI,Tao XU. Complications and management for penile augmentation with acellular dermal matrix [J]. Journal of Peking University(Health Sciences), 2019, 51(4): 636-640.
[8] WANG Jian-wei, MAN Li-bo, HUANG Guang-lin, WANG Hai, Xu Xiao, ZHU Xiao-fei, LI Wei, LIU Zhen-hua. “3-step” strategy of transperineal anastomotic urethroplasty for the simple pelvic fracture urethral distraction defect in male patients [J]. Journal of Peking University(Health Sciences), 2018, 50(4): 617-620.
[9] XIE Tian-Peng, HUANG Xiao-Bo, XU Qing-Quan, YE Hai-Yun, YANG Qing-Ya, WANG Xiao-Feng. Balloon dilation by B ultrasound monitoring for treatment of urethral stricture: 5 case reports [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 657-658.
[10] HUANG Guang-Lin, MAN Li-Bo, WANG Hai, WANG Jian-Wei, DI Jian-Po, ZHU Xiao-Fei, ZHOU Ning, XU Xiao. Management of female urethral obliteration with the rotary excision appliance [J]. Journal of Peking University(Health Sciences), 2014, 46(4): 574-577.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!